Coinbase has announced the addition of Bio Protocol (BIO) and ResearchCoin (RSC) to its asset list, leading to significant market changes.
Listing on Coinbase
The addition of BIO and RSC to Coinbase's listing took place on July 29, 2025. This event attracted investors' attention and caused active changes in the token market.
Price Dynamics of BIO and RSC
The BIO token surged by 19% following the listing announcement, while RSC initially increased by 10% but struggled to maintain its achieved positions.
Transparency and Market Impact
Coinbase CEO Brian Armstrong commented on conflict of interest concerns related to his association with ResearchHub, assuring the independence of listing decisions. "All assets listed on Coinbase go through our Digital Asset Support Group (DASG) review" — he stated.
The listing of BIO and RSC on Coinbase has demonstrated the platform's influence on the market. The impact of these tokens will remain under analysts' scrutiny.
